Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3655095011 | Radionuclide imaging using 177LU-DOTA-HH1 | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3655244018 | Radionuclide imaging using tetulomab tetraxetan (177-Lu) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4589246011 | Radionuclide imaging using lilotomab satetraxetan (177-Lu) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4589247019 | Radionuclide imaging using lilotomab satetraxetan (177-Lu) (procedure) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Radionuclide imaging using lilotomab satetraxetan (177-Lu) | Is a | Nuclear medicine imaging procedure | true | Inferred relationship | Existential restriction modifier | ||
| Radionuclide imaging using lilotomab satetraxetan (177-Lu) | Method | Radionuclide imaging - action | true | Inferred relationship | Existential restriction modifier | 1 | |
| Radionuclide imaging using lilotomab satetraxetan (177-Lu) | Using substance | Lilotomab satetraxetan (177-Lu) | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR